company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1493821.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1493821.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,109016.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,109016.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1384805.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2057493.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,182163.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5845014.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8084670.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6699865.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,252563.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,28675.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,281238.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6418627.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,46902.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6465529.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6465529.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6465529.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,71800000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,71800000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71800000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q1,2010-07-01,2010-09-30,2011-11-04 16:27:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1003527.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1003527.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,107259.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,107259.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,896268.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1474258.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,175958.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5762305.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7412521.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6516253.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,3140607.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-53419.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3087188.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-3429065.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1679.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3427386.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3427386.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3427386.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75289346.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75289346.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68500000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q2,2010-10-01,2010-12-31,2012-02-08 08:41:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1097051.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1097051.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,98272.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,98272.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,998779.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1749453.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,224013.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7037847.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9011313.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8012534.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,21379.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,461915.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,483294.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7529240.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,73910.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7603150.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7603150.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-145944.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7457206.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75317976.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75317976.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74600000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q3,2011-01-01,2011-03-31,2012-05-08 16:26:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11115080.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11115080.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,104805.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,104805.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11010275.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1834851.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,246014.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6723420.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8804285.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2205990.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3174550.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3210965.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,36415.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2242405.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-9253.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2251658.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2251658.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-28042.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2279700.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75313349.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75313349.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75400000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2011.0,Q4,2011-04-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1144654.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1144654.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,95865.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,95865.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1048789.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1167523.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,211886.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4812252.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6191661.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5142872.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,7881.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,22074.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,29955.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5112917.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,13964.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5126881.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5126881.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-26114.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5100767.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,72900000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,72900000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75435131.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q1,2011-07-01,2011-09-30,2012-11-08 16:15:44+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,29655430.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,29655430.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,134189.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,134189.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29521241.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1690449.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,239678.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6415598.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8345725.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,21175516.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,20559.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-106395.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-85836.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21089680.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,422750.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20666930.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,20666930.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-26597.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,20693527.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75458494.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.27
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75964317.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.27
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76600000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q2,2011-10-01,2011-12-31,2013-02-07 16:48:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.27
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,970703.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,970703.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,90598.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,90598.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,880105.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1399655.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,194352.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6892141.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8486148.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7606043.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11384.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,102727.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,91343.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7514700.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-216714.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7297986.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7297986.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-31705.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7266281.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75490716.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75490716.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,72700000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q3,2012-01-01,2012-03-31,2013-05-08 16:22:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,963040.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,963040.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,106383.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,106383.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,856657.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1504949.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,200109.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6135576.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7840634.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6983977.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,-11384.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-9678.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5172.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3466.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6987443.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-10215.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6977228.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6977228.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-29158.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6948070.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75481007.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,76174377.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68900000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2012.0,Q4,2012-04-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1051418.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1051418.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,96431.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,96431.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,954987.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1272705.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,204392.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6793922.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8271019.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7316032.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,139179.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,29705.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,168884.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7147148.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19669.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7166817.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7166817.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-25932.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7140885.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,79300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75610238.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q1,2012-07-01,2012-09-30,2014-03-18 20:52:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,812151.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,812151.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,91819.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,91819.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,720332.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1713300.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,187310.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6425233.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8325843.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7605511.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1850.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2433725.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2435575.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5169936.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19706.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5189642.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5189642.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-23330.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5166312.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,73800000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,73800000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75671088.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q2,2012-10-01,2012-12-31,2014-02-10 16:13:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1736466.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1736466.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,93703.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,93703.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1642763.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1500963.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,221718.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8113574.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9836255.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8193492.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1591.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16752842.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,16754433.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,8560941.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-19879.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8580820.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8580820.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-27783.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8608603.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,78195891.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.11
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78447065.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,78300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q3,2013-01-01,2013-03-31,2014-05-07 17:02:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.11
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1361962.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1361962.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,110769.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,110769.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1251193.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1667246.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,212955.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7048455.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8928656.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7677463.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-132063.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,123455.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8608.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7686071.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24574.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7710645.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7710645.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-27716.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7682929.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,78040005.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,78040005.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75900000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2013.0,Q4,2013-04-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5497821.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5497821.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1266369.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1266369.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4231452.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1732671.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,218032.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7514094.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9464797.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5233345.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6211.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5452.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11663.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5221682.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4501.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5226183.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5226183.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-25220.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5200963.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86700000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.06
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86700000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.06
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,82947124.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q1,2013-07-01,2013-09-30,2014-03-18 20:52:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.06
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1202450.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1202450.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,103071.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,103071.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1099379.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2042081.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,424510.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7243108.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9709699.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8610320.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,18305.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,12540.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,30845.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8579475.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-4501.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8574974.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8574974.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-25220.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8549754.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85500000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85500000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83174835.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q2,2013-10-01,2013-12-31,2015-02-04 16:21:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1154341.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1154341.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,90253.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,90253.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1064088.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2200526.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,243692.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8141744.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10585962.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9521874.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,15179.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25894.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10715.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9532589.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1372.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9533961.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9533961.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-28359.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9505602.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86400000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86400000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.11
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83340329.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q3,2014-01-01,2014-03-31,2015-05-06 16:36:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1186993.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1186993.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,68049.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,68049.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1118944.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2305747.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,246687.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10781212.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13333646.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12214702.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,16221.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8840.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,25061.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12189641.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6419.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12196060.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12196060.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-26553.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12169507.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84631567.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2014.0,Q4,2014-04-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1071998.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1071998.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,76286.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,76286.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,995712.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3819192.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,228637.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9392017.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13439846.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12444134.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,25072.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-11737.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,13335.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12430799.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11963.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12442762.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12442762.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-32342.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12410420.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,95500000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,95500000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,93098202.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q1,2014-07-01,2014-09-30,2015-11-04 16:30:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1002791.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1002791.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,68983.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,68983.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,933808.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1856036.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,174795.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10364850.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12395681.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11461873.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,11216.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11899.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,23115.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11438758.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,26892.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11465650.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11465650.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-30415.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11435235.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,95300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,95300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,93157279.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q2,2014-10-01,2014-12-31,2016-02-03 16:31:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1182698.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1182698.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,72771.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,72771.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1109927.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1564536.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,285708.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,10385422.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12235666.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11125739.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,720795.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,32838.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,28873.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-659084.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11784823.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3327.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11788150.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11788150.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-32003.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11756147.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,90400000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,90400000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,93351708.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q3,2015-01-01,2015-03-31,2016-05-04 16:31:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2395604.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2395604.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46875.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46875.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2348729.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1863162.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,79731.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11593599.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,13536492.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11187763.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1369955.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,176579.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-30223.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1223599.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12411362.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16047.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12427409.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12427409.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-26845.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12400564.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,94100000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,94100000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,93314872.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2015.0,Q4,2015-04-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,730878.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,730878.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,58264.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,58264.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,672614.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1724294.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,143521.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12913130.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14780945.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14108331.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1369955.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,91958.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-10461.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1288458.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15396789.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19250.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15416039.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15416039.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-22217.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15393822.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,96200000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,96200000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94595826.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q1,2015-07-01,2015-09-30,2016-11-02 16:51:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,671104.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,671104.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,64519.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,64519.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,606585.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1655841.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,386696.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14261676.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16304213.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15697628.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1369956.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,83762.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6950.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1279244.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16976872.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3204250.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13772622.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13772622.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-26572.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13746050.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,91600000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,91600000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94664758.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q2,2015-10-01,2015-12-31,2017-02-09 18:19:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,899079.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,899079.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,337675.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,337675.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,561404.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1580824.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,248425.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13298860.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15128109.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14566705.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1369955.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,81911.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-38699.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1326743.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15893448.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-1871772.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14021676.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14021676.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-25631.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13996045.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,93300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,93300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94748252.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q3,2016-01-01,2016-03-31,2017-05-10 16:16:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,931939.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,931939.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-460458.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-460458.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1392397.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1602041.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,248358.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13018334.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,1159000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16027733.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14635336.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1370134.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,80369.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2210.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1287555.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15922891.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2772.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15925663.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15925663.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-24580.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15901083.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,95200000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.16
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,95200000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.16
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,94770000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2016.0,Q4,2016-04-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.16
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,741806.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,741806.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,255105.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,255105.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,486701.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,691584.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,215856.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14525864.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15433304.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-14946603.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1369955.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,85206.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2459.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1282290.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-16228893.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16228893.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16228893.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-31045.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16197848.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,95300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,95300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95883729.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q1,2016-07-01,2016-09-30,2017-11-09 16:44:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,384170.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,384170.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,46762.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,46762.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,337408.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2763956.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,185075.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12748026.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15697057.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15359649.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1369956.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,69756.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7788314.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9088514.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24448163.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24448163.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24448163.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-779.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24447384.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,106300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,106300000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104657280.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q2,2016-10-01,2016-12-31,2018-02-08 16:16:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1323439.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1323439.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,135585.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,135585.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1187854.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10514243.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,302509.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12491290.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23308042.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22120188.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1369955.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,64574.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-35894789.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-37200170.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-59320358.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-59320358.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-59320358.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-14340.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-59306018.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,107800000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.55
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,107800000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.55
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,107839947.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q3,2017-01-01,2017-03-31,2018-05-09 16:45:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.55
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,641585.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,641585.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,-437452.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,-437452.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1079037.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,15139217.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,169560.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12010820.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,483000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27802597.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26723560.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1370134.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,211464.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-25366356.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26525026.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-53248586.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-53268586.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-53268586.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13836.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-53254750.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,104200000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.52
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,104200000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.52
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,104536000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2017.0,Q4,2017-04-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.52
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,690000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,690000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,70000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,70000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,620000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4650000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,226000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17342000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22218000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21598000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15652000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,416000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-81928000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-97164000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-118762000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-118762000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-118762000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-17000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-118745000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,122400000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.97
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,122400000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.97
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,122550000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q1,2017-07-01,2017-09-30,2018-11-07 16:16:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.97
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,597284.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,597284.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,496610.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,496610.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,100674.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2842379.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1189884.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25495536.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29527799.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-29427125.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,273991.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,382083.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26791775.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,26899867.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2527258.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2527258.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2527258.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13662.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2513596.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,125700000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,125700000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,154486782.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q2,2017-10-01,2017-12-31,2018-02-08 16:16:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13131000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5799000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38239000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,57169000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-57169000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10142000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1694000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1408000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7040000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-64209000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-64209000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-64209000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-40000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-64169000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,188700000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,188700000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,186937000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2018.0,Q3,2018-01-01,2018-09-30,2019-10-30 16:07:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,13595000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,7881000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,58172000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,79648000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-79648000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9959000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2203000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7756000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-87404000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-87404000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-87404000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-67000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-87337000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,189900000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.46
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,189900000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.46
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,191052000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q1,2018-07-01,2019-03-31,2020-05-06 16:08:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.46
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7899000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6346000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52923000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,67168000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-67168000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10625000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1840000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8785000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-75953000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-75953000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-75953000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-75953000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,189900000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.4
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,189900000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.4
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,191745000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:05:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.4
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11880000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,5933000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,68958000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,86771000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-86771000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9747000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,2195000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7552000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-94323000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,0.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-94323000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-94323000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-31000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-94292000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,192400000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,192400000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,191981000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q3,2019-07-01,2019-09-30,2019-10-30 16:07:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,295000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,295000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,295000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10429000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,6299000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,74818000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,91546000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-91251000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10006000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1618000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8388000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-99639000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-99639000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-99639000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-31000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-99608000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,194100000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.49
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,194100000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.49
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,193617000.0
Immunomedics Inc,IMMU,5493007ZU7DDO8PSIM59,0000722830,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.49
